Paid Clinical Trials Bakersfield

Discover 29 paid clinical trials in Bakersfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 29

LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Recruiting

PHASE3

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

Arcadia CA, Baldwin Park CA, West Covina CA, Bellflower CAshow 38 more

Code:

NCT06372964

Conditions

Bipolar Depression

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Lumateperone

Placebo

RemibrutinibA Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Bakersfield CA, Lancaster CA, Huntington Beach CA, Sandy UTshow 27 more

Code:

NCT05976243

Conditions

Chronic Inducible Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Placebo

FF/UMEC/VI vs. FF/VIA Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Recruiting

PHASE3

Sponsor:

GlaxoSmithKline

Location:

Bakersfield CA, Rolling Hills Estates CA, Huntington Beach CA, Mission Viejo CAshow 32 more

Code:

NCT05757102

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

FF/UMEC/VI

ELLIPTA

FF/VI

BI 764524A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Bakersfield CA, Santa Maria CA, Glendale CA, Beverly Hills CAshow 26 more

Code:

NCT06321302

Conditions

Diabetic Retinopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BI 764524

Sham comparator to BI 764524

Aflibercept (Eylea®) - US only

BEM/RZR vs. SOF/VELC-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

Recruiting

PHASE3

Sponsor:

Atea Pharmaceuticals, Inc.

Location:

Bakersfield CA, Mesa AZ, San Antonio TX, Arlington TXshow 15 more

Code:

NCT06868264

Conditions

HEPATITIS C VIRUS CHRONIC INFECTION

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemnifosbuvir-Ruzasvir (BEM/RZR)

Sofosbuvir-Velpatasvir (SOF/VEL)

DupilumabEfficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Bakersfield CA, La Jolla CA, Calgary, Edmontonshow 19 more

Code:

NCT05263206

Conditions

Pruritus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Placebo

Fexofenadine (loratadine if not available)

Moisturizer

PovorcitinibA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Recruiting

PHASE2

Sponsor:

Incyte Corporation

Location:

Bakersfield CA, Upland CA, Vancouver, San Antonio TXshow 23 more

Code:

NCT05851443

Conditions

Moderate to Severe Asthma

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

povorcitinib

placebo

ICS-LABA

Onvansertib & BevacizumabStudy of Onvansertib in Combination with FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants with a KRAS or NRAS Mutation

Recruiting

PHASE2

Sponsor:

Cardiff Oncology

Location:

Bakersfield CA, Los Angeles CA, Whittier CA, Torrance CAshow 34 more

Code:

NCT06106308

Conditions

Metastatic Colorectal Cancer

CRC

KRAS/NRAS Mutation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Onvansertib

FOLFIRI

Bevacizumab

FOLFOX

Sacituzumab TirumotecanA Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Recruiting

PHASE1

PHASE2

Sponsor:

Merck Sharp & Dohme LLC

Location:

Bakersfield CA, Chicago IL, Sherbrooke

Code:

NCT06637423

Conditions

Non-Muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab tirumotecan

RGX-314RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)

Recruiting

PHASE2

Sponsor:

AbbVie

Location:

Bakersfield CA, Santa Barbara CA, Beverly Hills CA, Pasadena CAshow 20 more

Code:

NCT04567550

Conditions

Diabetic Retinopathy (DR)

Center-Involved Diabetic Macular Edema (CI-DME)

Eligibility Criteria

Sex: All

Age: 25 - 70+

Healthy Volunteers: Not accepted

Interventions

ABBV-RGX-314 Dose 1

ABBV-RGX-314 Dose 2

ABBV-RGX-314 Dose 3

Topical Steroid

ABBV-RGX-314 Dose 4